Publicaties 2020

• Moerlie AR, van Uden RC, Mantel-Teeuwisse AK, van den Bemt PM, Becker ML. Inpatient prescribing of dual antiplatelet therapy according to the guidelines: a prospective intervention study. Pharm Pract (Granada). 2020 Apr-Jun;18(2):1803. doi: 10.18549/PharmPract.2020.2.1803.
• Jankelson L, Karam G, Becker ML, Chinitz LA, Tsai MC. QT prolongation, torsades de pointes, and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: A systematic review. Heart Rhythm. 2020 May 11:S1547-5271(20)30431-8. doi: 10.1016/j.hrthm.2020.05.008.
• Becker ML, van Uden RCAE, Giezen TJ, Meijer K, Houtenbos I, van den Bemt PMLA. Drug-drug interactions with metronidazole and itraconazole in patients using acenocoumarol.Eur J Clin Pharmacol. 2020 Jun 10. doi: 10.1007/s00228-020-02930-z.
• Minnema LA, Giezen TJ, Egberts TCG, Leufkens HGM, Gardarsdottir H. Adverse events related to biologicals used for patients with multiple sclerosis: a comparison between information originating from regulators and information originating from the scientific community. Eur J Neurol. 2020 Jul;27(7):1250-1256. doi: 10.1111/ene.14259
• Berger FA, van der Sijs H, Becker ML, van Gelder T, van den Bemt PM. Development and validation of a tool to assess the risk of QT drug-drug interactions in clinical practice. BMC Med Inform Decis Mak. 2020 Jul 23;20(1):171. doi: 10.1186/s12911-020-01181-3.
• Visser BJ, Korevaar DA, Mokhles MM, Vermeer-Pragt W, de Boer A, Giezen TJ. Hoe bereikt een nieuw geneesmiddel de patiënt?. Ned Tijdschr Geneeskd. 2020 Jul 30;164:D4859.
• Becker ML, Baypinar F, Pereboom M, Lilih S, van der Hoeven RTM, Giezen TJ, Kingma HJ. The effect of medication related clinical decision support at the time of physician order entry. Int J Clin Pharm. 2020 Sep 29. doi: 10.1007/s11096-020-01121-1.
• Smit C, van Schip AM, van Dongen EP, Brüggemann RJ, Becker ML, Knibbe CA. Dose recommendations for gentamicin in the real-world obese population with varying body weight and renal (dys)function. J Antimicrob Chemother. 2020 Nov 1;75(11):3286-3292. doi: 10.1093/jac/dkaa312.
• Alsamil AM, Giezen TJ, Egberts TC, Leufkens HG, Vulto AG, van der Plas MR, Gardarsdottir H. Reporting of quality attributes in scientific publications presenting biosimilarity assessments of (intended) biosimilars: a systematic literature review. Eur J Pharm Sci. 2020 Nov 1;154:105501. doi: 10.1016/j.ejps.2020.105501
• Minnema LA, Giezen TJ, Hoekman J, Egberts TCG, Leufkens HGM, Gardarsdottir H. Regulatory Safety Learning Driven by the Mechanism of Action: The Case of TNF-α Inhibitors. Clin Pharmacol Ther. 2020 Dec 5. doi: 10.1002/cpt.2127.